Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cabaletta Bio

1.32
+0.04003.13%
Pre-market: 1.30-0.0200-1.52%08:41 EDT
Volume:467.49K
Turnover:609.16K
Market Cap:66.98M
PE:-0.56
High:1.35
Open:1.25
Low:1.23
Close:1.28
Loading ...
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 02, 2022

Major Issues Report

8-K - Current report
May 18, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

Major Issues Report

8-K - Current report
May 02, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 17, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2022

Major Issues Report

8-K - Current report
Mar 14, 2022

Major Issues Report

8-K/A [Amend] - Current report
Mar 03, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 14, 2021

Major Issues Report

8-K - Current report